Analysed Galmed Pharmaceuticals Ltd (GLMD:NASDAQ) News Sources
Zydus Lifesciences to launch generic semaglutide injection for weight loss, diabetes after Ozempic’s patent expiry
The Financial Express
Gaudium IVF & Women Health IPO to list at discount? Here's what GMP signals ahead of debut
Mint on MSN
Type 2 diabetes: As Semaglutide goes off patent, drugmakers compete on differentiation, not just price
Business Today on MSN
What is the current price of Galmed Pharmaceuticals Ltd (GLMD:NASDAQ)?
The current price of Galmed Pharmaceuticals Ltd (GLMD:NASDAQ) is $0.65.
Galmed Pharmaceuticals Ltd (GLMD:NASDAQ) absolute price change since previous trading day?
The absolute price change of Galmed Pharmaceuticals Ltd (GLMD:NASDAQ) since the previous trading day is $-0.01.
Galmed Pharmaceuticals Ltd (GLMD:NASDAQ) percentage price change since previous trading day?
The percentage price change of Galmed Pharmaceuticals Ltd (GLMD:NASDAQ) since the previous trading day is -1.52%.
What is This Week's average sentiment score for Galmed Pharmaceuticals Ltd (GLMD:NASDAQ)?
This Week's average sentiment score for Galmed Pharmaceuticals Ltd (GLMD:NASDAQ) is 73 out of 100.
What is This Week's average sentiment for Galmed Pharmaceuticals Ltd (GLMD:NASDAQ)?
This Week's sentiment for Galmed Pharmaceuticals Ltd (GLMD:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.